Cargando…
In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles
BACKGROUND: The objective of this study was to survey the therapeutic function of curcumin-encapsulated poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gammabenzyl l-glutamate) (PBLG-PEG-PBLG) (P) on diabetic cardiomyopathy (DCM) via cross regulation effect of calcium-sensing receptor (CaS...
Autores principales: | Tong, Fei, Chai, Rongkui, Jiang, Haiying, Dong, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892954/ https://www.ncbi.nlm.nih.gov/pubmed/29662310 http://dx.doi.org/10.2147/IJN.S153763 |
Ejemplares similares
-
In vitro/vivo Drug Release and Anti-Diabetic Cardiomyopathy Properties of Curcumin/PBLG-PEG-PBLG Nanoparticles [Retraction]
Publicado: (2021) -
Osteogenic Properties of PBLG-g-HA/PLLA Nanocomposites
por: Liao, Lan, et al.
Publicado: (2014) -
Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity
por: Feng, Qiyi, et al.
Publicado: (2021) -
Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
por: Duan, Dongyu, et al.
Publicado: (2018) -
Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)